Thirdly, it has been reported that some novel biomarkers (interleukin 18 and kidney injury molecule‐1) could predict the occurrence of subclinical kidney injury,32 which can act as a promising tool to improve the early diagnosis. Here, IL18 is linked to kidney injury.